Viewing Study NCT02511795


Ignite Creation Date: 2025-12-24 @ 1:37 PM
Ignite Modification Date: 2026-04-25 @ 11:25 PM
Study NCT ID: NCT02511795
Status: COMPLETED
Last Update Posted: 2019-11-07
First Post: 2015-07-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: AZD1775 Combined With Olaparib in Patients With Refractory Solid Tumors
Sponsor: AstraZeneca
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: D6010C00005
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators